Fred L Mazzilli Foundation Inc
Nonprofit profile at a glance
- EIN
- 463548171
- IRS 990-EZ coverage
- 2021–2025
- Forms available
- Form 990-EZ 2025, Form 990-N 2016
- Location
- Bellmore, NY, USA
- Phone
- 6462872526
- Rating
- 89
- Verdict
- STRONG
- Rating confidence
- Moderate
- Sector
- Voluntary Health Associations & Medical Disciplines N.E.C.
Reported finances
- Revenue
- $80,355
- Expenses
- $72,653
- Assets
- $46,073
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
4 people listed
Executive titles in this filing
- Joann Zolotin (President)
- Lee Mazzilli (Vice President)
- Dani Mazzilli (Vice President)
People named in this filing
- Joann Zolotin (President)
- Lee Mazzilli (Vice President)
- Dani Mazzilli (Vice President)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Lung Cancer Awareness and Screenings
What it reported doing in 2025
Annual grant to New York Presbyterian Brooklyn Methodist Hospital to operate a lung cancer screening program. According to the American Cancer Society, about 1 in 19 Americans will be diagnosed with lung cancer during their lifetime. Although the number of new cases continues to decline, lung cancer remains the leading cause of cancer- related deaths. For 2026, the American Cancer Society estimates more than 229,000 new lung cancer cases and approximately 125,000 deaths. These numbers include individuals with and without a history of smoking. While smoking remains the strongest risk factor, lung cancer also occurs in nonsmokers, reinforcing the importance of awareness and early detection. In 2025, the foundation's lung screening program continued its rapid growth. Building on expanding staffing, patient navigation, and advanced imaging technology, the program significantly increased it reach. The number of lung cancer screenings CT scans doubled, from 404 in 2023 to 803 in 2025. As screening volume grew, so did the number of patients with findings that required closer monitoring or diagnostic follow up. In 2025, 1 in 10 patients screened needed additional evaluation. This growth reflects the program's expanding reach among high risk individuals. More importantly, it shows our increasing ability to detect concerning findings earlier, connect patients quickly to follow up care and improve outcomes through timely fashion. In 2025, with our partnership with NY Presbyterian Methodist Hospital, the program expanded further with the addition of Erbe Cryo technology: a tool that represents the next generation of precision lung diagnostics. Erbe Cryo allows physicians to safely obtain larger, more intact samples, often leading to more acute diagnoses, especially for early lung nodules and subtle abnormalities. Together with NY Presbyterian Methodist Hospital, we have made early lung cancer detection, advanced diagnostics, and timely treatment a reality.
Operating model
- Revenue model
- Other-operating. 100% of the money available for current operations came from other operating revenue.
- Distribution model
- Grant intermediary. The nonprofit sent 100% of its reported program spending out as grants.
The verdict
STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. Assets have declined or grown slowly and total assets are small relative to annual expenses; liquid coverage is unknown.
Rating breakdown
- Financial Efficiency: 84
- Transparency & Controls: 100
- Sustainability: 53
- Growth: 80
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 80.9%; rating input score 81
- Program expense ratio: 89.5%; rating input score 89
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
Sustainability
- Operating margin: 9.6%; rating input score 60; 60th percentile among comparable filings
- Total-asset coverage ratio: 0.63; rating input score 36; 36th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 66; 66th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: 18.3% per year; rating input score 100; 80th percentile among comparable filings
- Revenue growth: 12.8% per year; rating input score 100; 84th percentile among comparable filings
- Asset growth: -4.5% per year; rating input score 0; 25th percentile among comparable filings
Details
- Where the money goes: 80.9% of revenue deployed · 89.5% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $65K in reported program spending
- Leadership: top reported pay $0 · 4 people listed
- Consistency: 9 of 9 current checks pass
- Schedules: 4 filed schedules
- Filing history: 5 filing years from 2021 to 2025
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Growth: Asset growth scored 0/100.
- Moderate — Sustainability: Total-asset coverage ratio scored 36/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.